Clinical trials: Nasal Polyposis

Nasal Polyps

Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)

• Completed
• Age: 6 to 17 years
• Phase 3
• Results posted

The purpose of this study is to evaluate the safety and efficacy of Nasonex® (Mometasone Furoate Nasal Spray(MFNS)) in the treatment of nasal polyps in pediatric subjects between the ages of 6 and less than 18 years old.

Trial name

NCT00378378

Testing

Mometasone Furoate Nasal Spray (MFNS)

Volunteers

127 people

Sponsor

Organon and Co